Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab vs placebo in undifferentiated arthritis at high risk for rheumatoid arthritis (P1200/001)
2007-004694-26Phase 3Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Sep 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in undifferentiated arthritis (UA) and rheumatoid arthritis (RA) comparing Infliximab induction with Placebo induction (2 arms). Primary endpoint: Primary synovitis and MRI outcome. Started Sep 2007; status: completed.
02
Drugs
infliximab
03
Conditions
undifferentiated arthritis (UA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-004694-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004694-26.